Latest News

New research shows that while niacin added to statin therapy increases HDL cholesterol levels it does not improve HDL functionality

While two large clinical trials recently showed that adding niacin to statin therapy failed to improve clinical outcomes despite a significant increase in HDL-C levels, little is known about exactly why the increased HDL-C levels did not reduce the risk of cardiovascular events, including heart attack and stroke. Now, a small study has shown that while niacin increased measured levels of HDL-C, it did not improve the functionality of HDL. This may provide an explanation for the failure of niacin to further reduce cardiovascular risk.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • With racial segregation declining between neighborhoods, segregation now taking new form

  • Gene variants modifying Huntington's symptom onset may lead to new therapeutic strategies

  • Prescription for medical students: A day at the art museum?

  • Aquariums deliver health and wellbeing benefits

  • Teaching med students about health disparities builds their confidence

  • Antibiotics increase risk of hearing loss in patients with deadly bacterial infections

  • Changing clocks, changing seasons: Scientists find role for neuronal plasticity

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Generally accepted tools used to select patients for aneurysm treatment in need of further evaluation

  • Analysis of post deployment health assessment forms indicates risks of alcohol abuse among service members returning from deployment

  •